Beijing Bohui Innovation Biotechnology Group Co., Ltd. (300318.SZ)
- Previous Close
5.80 - Open
5.94 - Bid 5.84 x --
- Ask 5.85 x --
- Day's Range
5.76 - 5.86 - 52 Week Range
4.53 - 7.31 - Volume
9,068,840 - Avg. Volume
18,039,278 - Market Cap (intraday)
4.779B - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-0.02 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date Jul 12, 2018
- 1y Target Est
--
Beijing Bohui Innovation Biotechnology Group Co., Ltd. engages in the research and development, production, sale, and after-sale service of diagnostic products in China. It offers GenPlex, a microfluidic automated nucleic acid detection system, immunofluorescence detection products, and human trace element detection products; and chemical analysis products, such as atomic fluorescence; mass spectrometry and separation analysis, life sciences related consumables, and ICP spectroscopy. The company was formerly known as Beijing Bohui Innovation Biotechnology Co., Ltd. and changed its name to Beijing Bohui Innovation Biotechnology Group Co., Ltd. in August 2021. Beijing Bohui Innovation Biotechnology Group Co., Ltd. was founded in 2001 and is headquartered in Beijing, China.
www.bohui-tech.comRecent News: 300318.SZ
View MorePerformance Overview: 300318.SZ
Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 300318.SZ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 300318.SZ
View MoreValuation Measures
Market Cap
4.78B
Enterprise Value
5.87B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
6.04
Price/Book (mrq)
3.48
Enterprise Value/Revenue
7.41
Enterprise Value/EBITDA
3.83k
Financial Highlights
Profitability and Income Statement
Profit Margin
-1.85%
Return on Assets (ttm)
0.40%
Return on Equity (ttm)
-1.41%
Revenue (ttm)
791.3M
Net Income Avi to Common (ttm)
-14.67M
Diluted EPS (ttm)
-0.02
Balance Sheet and Cash Flow
Total Cash (mrq)
286.85M
Total Debt/Equity (mrq)
58.47%
Levered Free Cash Flow (ttm)
-138.44M